{
    "Trade/Device Name(s)": [
        "MicroScan\u00ae MICroSTREP plus Panels",
        "MicroScan\u00ae MICroSTREP plus Panel"
    ],
    "Submitter Information": "Siemens Healthcare Diagnostics, Inc.",
    "510(k) Number": "K091949",
    "Predicate Device Reference 510(k) Number(s)": [
        "K062773",
        "K020626"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "LTT",
        "LRG"
    ],
    "Summary Letter Date": "January 14, 2010",
    "Summary Letter Received Date": "January 19, 2010",
    "Submission Date": "June 16, 2009",
    "Regulation Number(s)": [
        "21 CFR 864.1640"
    ],
    "Regulation Name(s)": [
        "Antimicrobial Susceptibility Test Powder"
    ],
    "Analyte Class(es)": [
        "microbiology"
    ],
    "Analyte(s)": [
        "Penicillin"
    ],
    "Specimen Type(s)": [
        "Colonies grown on solid media of aerobic streptococci"
    ],
    "Specimen Container(s)": [],
    "Instrument(s)/Platform(s)": [
        "MicroScan WalkAway instrument"
    ],
    "Method(s)/Technology(ies)": [
        "Broth microdilution susceptibility test"
    ],
    "Methodologies": [
        "Antimicrobial susceptibility testing"
    ],
    "Submission Type(s)": [
        "Panel"
    ],
    "Document Summary": "FDA 510(k) summary for MicroScan MICroSTREP plus Panel for penicillin susceptibility testing using updated Streptococcus pneumoniae interpretive criteria",
    "Indications for Use Summary": "Used to determine quantitative and/or qualitative antimicrobial agent susceptibility of colonies of aerobic streptococci, including Streptococcus pneumoniae, via updated penicillin interpretative criteria for meningitis and non-meningitis",
    "fda_folder": "Microbiology"
}